D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
PCVX holding history
Vaxcyte, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PCVX overviewAll 13F holders of PCVXFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,901,872
- Value
- $110.6M
- % of portfolio
- 0.1%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,901,872 | $110.6M | 0.1% | −963,446−33.6% | Reduced | Holders |
| Q1 2026 | 2,865,318 | $166.5M | 0.1% | −765,735−21.1% | Reduced | Holders |
| Q4 2025 | 3,631,053 | $167.5M | 0.1% | −659,737−15.4% | Reduced | Holders |
| Q3 2025 | 4,290,790 | $154.6M | 0.1% | +1,202,340+38.9% | Added | Holders |
| Q2 2025 | 3,088,450 | $100.4M | 0.1% | +2,220,559+255.9% | Added | Holders |
| Q1 2025 | 867,891 | $32.8M | <0.1% | +92,238+11.9% | Added | Holders |
| Q4 2024 | 775,653 | $63.5M | 0.1% | +352,155+83.2% | Added | Holders |
| Q3 2024 | 423,498 | $48.4M | 0.1% | +193,291+84.0% | Added | Holders |
| Q2 2024 | 230,207 | $17.4M | <0.1% | −137,042−37.3% | Reduced | Holders |
| Q1 2024 | 367,249 | $25.1M | <0.1% | −71,062−16.2% | Reduced | Holders |
| Q4 2023 | 438,311 | $27.5M | <0.1% | −100,073−18.6% | Reduced | Holders |
| Q3 2023 | 538,384 | $27.4M | <0.1% | −274,528−33.8% | Reduced | Holders |
| Q2 2023 | 812,912 | $40.6M | 0.1% | +18,005+2.3% | Added | Holders |
| Q1 2023 | 794,907 | $29.8M | <0.1% | −177,414−18.2% | Reduced | Holders |
| Q4 2022 | 972,321 | $46.6M | 0.1% | +972,321 | New | Holders |